Products

Benralizumab (Gly-006CL)

Benralizumab (INN) is a monoclonal antibody which is being developed by MedImmune for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125).      

Specifications
Type
Humanized (from mouse) Whole antibody
Protein Chemical Formula
C6492H10060N1724O2028S42
Protein Average Weight
146.0 kg/mol
CAS NO.
1044511-01-4
Mechanism of Action
Interleukin 5 receptor antagonists
References
Alternative Names
MEDI-563 (BIW-8405); Anti-IL-5Rα Mab; Anti-IL5Ra monoclonal antibody; Anti-interleukin-5 receptor alpha monoclonal antibody; BIW-8405-IL-5R; KHK 4563;

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-381-2994    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2018 Creative-Biolabs All Rights Reserved